Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2024 Aug 29

PMID 39202472

Authors

Saira Rafaqat

Saima Sharif

Shagufta Naz

Sanja Gluscevic

Filiz Mercantepe

Ana Ninic

Aleksandra Klisic

Affiliations

Soon will be listed here.

Abstract

: This study aimed to examine the relationship between cardiometabolic risk factors and atrial fibrillation (AF) and the simultaneous presence of AF and metabolic syndrome (MetS) in the Pakistani population. : A total of 690 subjects were enrolled (n = 230 patients with AF, n = 230 patients with AF and MetS, and n = 230 controls). The associations between cardiometabolic parameters and AF with and without MetS were analyzed by univariable and multivariable binary regression analyses. : Body mass index (BMI), fasting blood glucose (FBG), and triglycerides (TG) were independently positively correlated, but the glomerular filtration rate (GFR) and sodium were independently negatively correlated with AF. An increase in BMI, FBG, and TG levels by one unit measure increased the probability by 55.1%, 20.6%, and 1.3%, respectively, for the AF occurrence. A decrease in GFR and sodium levels increased the probability by 4.3% and 33.6%, respectively, for the AF occurrence. On the other hand, uric acid was independently negatively correlated, whereas sodium was independently positively correlated, with MetS and AF. A decrease in uric acid levels and an increase in sodium levels by 1 unit measure increased the probability for MetS and AF by 23.2% and 7.5%, respectively. : Cost-effective and routinely measured parameters, i.e., BMI, FBG TG, GFR, and sodium levels, can be reliable indicators of AF, whereas serum uric acid and sodium levels are independently associated with AF and MetS in the Pakistani population. Timely recognition and the control of modifiable cardiometabolic risk factors are of great significance in the prevention of AF development.

References

Kumar S, Lim E, Covic A, Verhamme P, Gale C, Camm A . Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 74(17):2204-2215. DOI: 10.1016/j.jacc.2019.08.1031. View

Rafaqat S, Sharif S, Majeed M, Naz S, Saqib M, Manzoor F . Association of adiponectin gene expression with atrial fibrillation in a Pakistani populace. Sci Rep. 2023; 13(1):22589. PMC: 10730827. DOI: 10.1038/s41598-023-46388-2. View

Corry D, Eslami P, Yamamoto K, Nyby M, Makino H, Tuck M . Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008; 26(2):269-75. DOI: 10.1097/HJH.0b013e3282f240bf. View

Krijthe B, Heeringa J, Kors J, Hofman A, Franco O, Witteman J . Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol. 2013; 168(6):5411-5. DOI: 10.1016/j.ijcard.2013.08.048. View

Lee H, Shin S, Huang J, Lin M, Lin Y, Ke L . The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome. Lipids Health Dis. 2020; 19(1):210. PMC: 7507670. DOI: 10.1186/s12944-020-01386-5. View

Guan B, Li X, Xue W, Tse G, Bin Waleed K, Liu Y . Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Clin Lipidol. 2020; 14(1):133-142.e3. DOI: 10.1016/j.jacl.2019.12.002. View

Nieto F, Iribarren C, Gross M, Comstock G, Cutler R . Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis. 1999; 148(1):131-9. DOI: 10.1016/s0021-9150(99)00214-2. View

Zheng Y, Xie Z, Li J, Chen C, Cai W, Dong Y . Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations. BMC Cardiovasc Disord. 2021; 21(1):90. PMC: 7885417. DOI: 10.1186/s12872-021-01858-1. View

Suzuki S, Sagara K, Otsuka T, Kanou H, Matsuno S, Uejima T . Estimated glomerular filtration rate and proteinuria are associated with persistent form of atrial fibrillation: analysis in Japanese patients. J Cardiol. 2012; 61(1):53-7. DOI: 10.1016/j.jjcc.2012.07.016. View

10.

Javed S, Gupta D, Lip G . Obesity and atrial fibrillation: making inroads through fat. Eur Heart J Cardiovasc Pharmacother. 2020; 7(1):59-67. DOI: 10.1093/ehjcvp/pvaa013. View

11.

Deng Y, Liu F, Yang X, Xia Y . The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation. Front Cardiovasc Med. 2021; 8:641136. PMC: 7952317. DOI: 10.3389/fcvm.2021.641136. View

12.

Bjelakovic B, Stefanutti C, Bonic D, Vukovic V, Kavaric N, Saranac L . Serum uric acid and left ventricular geometry pattern in obese children. Atheroscler Suppl. 2019; 40:88-93. DOI: 10.1016/j.atherosclerosissup.2019.08.035. View

13.

Klisic A, Kocic G, Kavaric N, Jovanovic M, Stanisic V, Ninic A . Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2. Clin Exp Med. 2017; 18(2):283-290. DOI: 10.1007/s10238-017-0483-0. View

14.

Lee S, Lee S, Choi E, Kwon S, Yang S, Park J . Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Study. J Am Heart Assoc. 2021; 10(16):e020901. PMC: 8475027. DOI: 10.1161/JAHA.121.020901. View

15.

Zakynthinos G, Tsolaki V, Oikonomou E, Vavouranakis M, Siasos G, Zakynthinos E . Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders. J Pers Med. 2023; 13(9). PMC: 10533132. DOI: 10.3390/jpm13091323. View

16.

Tu Y, Liu Y, Chen S, Su H . Metabolic Syndrome and Its Components Are Associated with New-Onset Hyperuricemia in a Large Taiwanese Population Follow-Up Study. Nutrients. 2023; 15(5). PMC: 10004782. DOI: 10.3390/nu15051083. View

17.

Ocak G, Khairoun M, Khairoun O, Bos W, Fu E, Cramer M . Chronic kidney disease and atrial fibrillation: A dangerous combination. PLoS One. 2022; 17(4):e0266046. PMC: 8989340. DOI: 10.1371/journal.pone.0266046. View

18.

Zhong X, Jiao H, Zhao D, Teng J . Serum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study. Med Sci Monit. 2022; 28:e934007. PMC: 8892768. DOI: 10.12659/MSM.934007. View

19.

Brundel B, Ai X, Hills M, Kuipers M, Lip G, de Groot N . Atrial fibrillation. Nat Rev Dis Primers. 2022; 8(1):21. DOI: 10.1038/s41572-022-00347-9. View

20.

Barra S, Providencia R, Silva J, Gomes P, Seca L, Nascimento J . [Glomerular filtration rate: which formula should be used in patients with myocardial infarction?]. Rev Port Cardiol. 2012; 31(7-8):493-502. DOI: 10.1016/j.repc.2012.05.003. View